CTA-defined calcified nodules as a predictor of adverse outcomes following carotid revascularization
Neurosurgical Review · 10.11.2026 · 49 (1)
DOI: 10.1007/s10143-026-04565-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurosurgical Review, online erschienen am 10.11.2026. Verfasst von Hiroki Uchida und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, NHO Sendai Medical Center, 2-11-12 Miyagino, Sendai, Miyagi, 983-0045, Japan. h.uchida0206@gmail.com. Hauptthemen laut MEDLINE: Endarterectomy, Carotid, Carotid Stenosis, Computed Tomography Angiography, Calcinosis. Die Arbeit nennt 15 Literaturangaben.
Abstract (Originalsprache)
Carotid calcification can complicate carotid artery stenting (CAS), but the clinical impact may depend on calcification morphology rather than calcification burden alone. We retrospectively evaluated 92 patients who underwent carotid revascularization with either carotid endarterectomy (CEA) or CAS and classified preoperative CTA findings as no/spotty calcification (Group 1), outer calcification (Group 2), or a calcified nodule (CN) pattern directly abutting the contrast-enhanced lumen (Group 3). The primary composite endpoint comprised procedural failure, ischemic complications, or restenosis. The endpoint occurred in 4 of 83 patients (4.8%) in Groups 1/2 and in 5 of 9 patients (55.6%) in Group 3 (unadjusted OR, 24.69; 95% CI, 4.72-129.14; p < 0.001). In a parsimonious multivariable model including treatment modality and calcification pattern, Group 3 remained associated with the composite endpoint (adjusted OR, 49.05; 95% CI, 4.82-498.94; p = 0.001), whereas CEA was associated with lower risk (adjusted OR, 0.045; 95% CI, 0.003-0.664; p = 0.024). Among patients undergoing CAS, the endpoint occurred in 3 of 38 patients (7.9%) in Groups 1/2 and all 5 patients (100%) in Group 3 (p < 0.001). A CTA-defined CN pattern may identify lesions at particularly high risk for CAS-related technical failure or restenosis and may support consideration of CEA when surgically feasible.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, NHO Sendai Medical Center, 2-11-12 Miyagino, Sendai, Miyagi, 983-0045, Japan. h.uchida0206@gmail.com.
- Department of Neurosurgery, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan. h.uchida0206@gmail.com.
- Department of Neurosurgery, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.
- Department of Neurosurgery, Kohnan Hospital, Sendai, Miyagi, Japan.
ORCID-Profile: Hiroki Uchida
Zitieren
APA
Uchida, H., Tashiro, R., Kanoke, A., Sakata, H., & Endo, H. (2026). CTA-defined calcified nodules as a predictor of adverse outcomes following carotid revascularization. Neurosurgical Review, 49(1). https://doi.org/10.1007/s10143-026-04565-7
Vancouver
Uchida H, Tashiro R, Kanoke A, Sakata H, Endo H. CTA-defined calcified nodules as a predictor of adverse outcomes following carotid revascularization. Neurosurgical Review. 2026;49(1). doi:10.1007/s10143-026-04565-7
BibTeX
@article{Uchida2026,
author = {Uchida, Hiroki and Tashiro, Ryosuke and Kanoke, Atsushi and Sakata, Hiroyuki and Endo, Hidenori},
title = {CTA-defined calcified nodules as a predictor of adverse outcomes following carotid revascularization},
journal = {Neurosurgical Review},
year = {2026},
volume = {49},
number = {1},
doi = {10.1007/s10143-026-04565-7}
}
EUVIMED